TScan Therapeutics Inc.

NASDAQ: TCRX · Real-Time Price · USD
1.80
-0.01 (-0.55%)
At close: Aug 15, 2025, 3:59 PM
1.80
-0.28%
After-hours: Aug 15, 2025, 04:10 PM EDT

TScan Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-127.5M -89.22M -66.22M -48.63M
Depreciation & Amortization
4.11M 5.36M 5.14M 3.33M
Stock-Based Compensation
9.55M 5.21M 4.55M 2.52M
Other Working Capital
3.06M 17.66M -10.76M -5.91M
Other Non-Cash Items
-2.03M -315K 260K 9.16M
Deferred Income Tax
n/a n/a n/a -9.16M
Change in Working Capital
5.05M 17.61M -10.23M -5.9M
Operating Cash Flow
-110.82M -61.36M -66.5M -48.68M
Capital Expenditures
-3.83M -3.15M -4.22M -9.94M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-241.44M -77.61M n/a n/a
Sales Maturities Of Investments
192.66M 20M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-52.61M -60.76M -4.22M -9.94M
Debt Repayment
15.31M n/a 29.35M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
160.32M 93.03M -191K 291K
Financial Cash Flow
208.76M 135.44M 29.36M 189.67M
Net Cash Flow
45.33M 13.33M -41.37M 131.05M
Free Cash Flow
-114.65M -64.5M -70.73M -58.62M